Introduction
Chronic obstructive pulmonary disease (COPD) is an important cause of morbidity and mortality within the smoking population. 1, 2 It is predominantly a disease of males, though the incidence of the disease in women is increasing rapidly, probably due to increased cigarette smoking. 3 COPD encompasses both emphysema and chronic bronchitis and is characterised by an incompletely reversible limitation of the airway. 4 Its severity is graded using spirometry, analysing forced expiratory volume in the first second (FEV1) and forced vital capacity (FVC), and the FEV1:FVC ratio. 5 These clinical measurements can be made in primary care, where increasing numbers of people with COPD will be monitored and treated. 6 Incentives have been provided to accelerate the shift of management of COPD to primary care through the inclusion of a quality target for COPD monitoring in the new United Kingdom (UK) general practice contract. 7 Best practice has also been reinforced through the production of national guidance for the management of COPD. 8 The quality of COPD management in primary care will be measured using Read-coded data extracted from general practice (GP) computerised medical records. Such data will be measured by the Quality Management and Analysis System (QMAS) and will have financial rewards linked to it. 9 There is every incentive for UK general practitioners to improve their data quality ahead of these assessments. The quality of computer data is measured in terms of completeness, accuracy, currency and consistency of recording. 10, 11 There is an emerging consensus that an indicator of data quality is best achieved by looking at three areas: the reliability of data, by comparison with existing databases; combined with calculating sensitivity and positive predictive value. 12, 13 With the exception of data quality probes, which rely on a Boolean comparison of two features (such as prescribing thyroxine and diagnosis of hypothyroidism), and the work of the PRIMIS Team, little has been written about how a practice might assess the quality of data about an individual diagnosis. [14] [15] [16] [17] In the case of COPD there is no single drug that is a surrogate marker of the disease, making data quality probes unsuitable; and within the time-scale available it was not possible to address this issue via a data quality programme or educational intervention, the usual way we would recommend improving data quality in practice. 18, 19 Against the backdrop of a new quality-based contract, and the need to implement best practice, general practice diagnostic data need to be valid and reliable; we therefore developed a tool to assess data quality and used it to measure the quality of COPD diagnostic data.
Method
An overview of the eight steps of the methodology is shown in Table 1 . The table also shows the sources of information required to assess diagnostic data quality. The knowledge required is broad. It includes an understanding of the disease, the clinical computer system and its user interface, the coding system or terminology it uses to record data, information about the practice area, the nature of clinical practice, and how primary care professionals actually use the system. 1 Find out the expected prevalence of the diagnosis and define audit criteria
We performed a literature search using Medline to identify review articles about COPD, and the use of controlled vocabularies in primary care. We also looked up the Office of National Statistics data on the UK prevalence of COPD. 20 We then developed audit criteria based on this review. Data were extracted from the computer records under the following fields: gender; year of birth; smoking habit; history of asthma; last spirometry (date, location and results); recent hospital admission (for exacerbation of COPD); recent oral prescription of prednisolone (for an exacerbation of COPD). 'Recent' was defined as within 27 months to coincide with the length of time specified in the new General Medical Services (GMS) Contract. 7 2 How the diagnosis is recorded The coding system most commonly used in the UK is the Read Terminology, Version 2 (referred to as the Read codes and the process of using them as coding). 21 This system is hierarchical, consisting of parent and child codes. It is organised into chapters relating to body systems or parts of the clinical process (for example, symptoms, examination findings, and so on). The coding hierarchy and picking lists of terms and codes were investigated to identify which terms were prominent when a clinician typed the terms 'bronchitis' , 'emphysema' or 'COPD' . The picking list displayed by the EMIS (Egton Medical Information System), the computer system used, is shown in Figure 1 . The 'Clue' search engine was used to check the validity of the codes the EMIS system generated. 22, 23 We asked primary care clinicians how they used this interface and coded COPD patients.
Population denominator
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Prevalence and its inference on reliability
The prevalence of the disease should be calculated and the age-sex profile and other data held about the practice should enable some inference to be drawn about the reliability of the data. If comparisons are to be made between practices then the population needs to be standardised. This can either be done using the relevant national population or by using the European standard population. The latter has become the standard comparator used within the UK health service. 25 
Completeness of the data
Additional searches were performed to find any patients who were likely to have a diagnosis of COPD, but were not in the audit result due to incorrect coding. Criteria used were: age over 45; repeat prescription for ipratropium or tiatropium; not coded as asthma; not coded as COPD. In addition a search was carried out on patients aged over 45 years who had been newly prescribed salbutamol or other beta-agonist since 1996, when a detailed review of all patients with possible COPD had been carried out. 6 6 Accuracy of the data
The clinical records of the patients that the computer search identified as having a diagnosis of COPD were examined. This consisted of looking at all the free text in the computer notes to validate the diagnosis; if the information was not found then the written record was examined. Important factors in determining the accuracy of the coding were: age of patient; smoking status; history of asthma; current monitoring and treatment regimens.
Consistency and currency
Records of those with an accurate, coded diagnosis of COPD, but who did not have a coded FEV1 measurement in the last 27 months were examined. Free-text entries and hospital outpatient correspondence were read, and date and result of the patient's last spirometry were noted, if recorded.
Sensitivity and positive predictive value
Data were collated and used to calculate the sensitivity of searching for patients with a diagnosis of COPD (that is, how many patients with COPD did the search strategy miss?). The positive predictive value was calculated to highlight the effectiveness of using coded data for COPD analysis (that is, the likelihood that someone with a code for COPD actually has the disease).
Results 1 Literature review and audit criteria
The information about COPD and data quality has been included within the introduction; and the audit criteria within the method. The expected prevalence rate is between 3% and 10%, though it is recognised to be under-recorded and under-treated. 2, 26 The objective of the study was to develop a generalisable method to assess diagnostic data quality and to use COPD as an exemplar to test the method.
How the diagnosis is coded
The patients' records at this practice are all computerised, and any correspondence is scanned in. The practice uses EMIS as its clinical computer system. 22 The Read codes for bronchitis, COPD and asthma are confusing, making it easy to miscode and create inaccurate diagnoses. All the respiratory chapter codes start with an H. However, bronchitis appears in two parts: H06 for acute and H3z for chronic. For a busy clinician it can be all too easy to select the wrong code (see Figure 1) . The hierarchy of Read codes for COPD is such that several diagnoses fall under the broad heading of 'Chronic Obstructive Pulmonary Disease' . Figure 3 illustrates some of the diagnoses that may be found when searching the H3 hierarchy, and the potentially difficult choice that a general practitioner might have to make.
Several of the clinicians in the practice were confused about coding and the coding hierarchy. Several commented on the apparently absurd location of the H33 (asthma) code as a child code of H3 (bronchitis). The template for data entry was correct and linked to appropriate codes. Coding of smoking habit was also examined, and nearly half of the clinicians thought that 137: 'smoking status' was a code that indicated that a patient was an active smoker of some sort. They did not realise that selection of this code was ambiguous, as it contains child codes that included
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Results 1 Literature review and audit criteria
How the diagnosis is coded
Several of the clinicians in the practice were confused about coding and the coding hierarchy. Several commented on the apparently absurd location of the H33 (asthma) code as a child code of H3 (bronchitis). The template for data entry was correct and linked to appropriate codes. Coding of smoking habit was also examined, and nearly half of the clinicians thought that 137: 'smoking status' was a code that indicated that a patient was an active smoker of some sort. They did not realise that selection of this code was ambiguous, as it contains child codes that included never smoked (1371), passive smoker (137I), chews tobacco (137W), as well as codes for being a current and ex-smoker.
Population denominator
The audit was carried out in an undergraduate teaching practice, where ERF spent his final year GP attachment. The practice was involved in COPD research from 1995 to 1997. 6 This is a six-whole time equivalent practice located in Guildford, Surrey. The practice population is 10 975. The age and sex profile can be seen in Figure 2 , and is typical for the south of England. There is a dip in the number of older age-group children and those in their early twenties associated with people moving away for education, university and at the start of their working lives. There is then a 'bulge' in the graph, associated with the 1960s baby boom. Unusually for the UK, there is an excess of men between 40 and 54, associated with those who work in a high-cost housing area leaving their family elsewhere. Ethnicity coding is present for less than 5% of the practice population.
Prevalence and the inferred reliability of the data
A total of 190 patients were initially identified as having a diagnosis of COPD, a point prevalence of 18.6 per 1000 registered patients. After the inaccurate diagnoses were excluded and missed diagnoses added this was estimated to be 13.3 per 1000. This is low compared with the expected 3% to 10%, but compatible with the area's relative affluence, relatively small elderly population and low rate of cigarette smoking.
Completeness
A total of 38 more patients with COPD were missed from the initial search; these patients were identified by searching for those receiving treatment for COPD who lack a diagnosis. Only 10% (19/190) had FEV1 values within 27 months identified from the computer search (see Figure 4) . Smoking data were present for 171/190 (90% of patients identified by the initial search). These data showed 38.6% (66/171) to be current smokers, 38.6% (66/171) to be ex-smokers, 17% (29/171) were coded as having never smoked tobacco and 5.8% (10/171) had the ambiguous higher order 'smoking status' code (137).
Accuracy
On inspection of the computerised records it was possible to exclude the diagnosis of COPD in 24.7% (47/190) patients because of an inaccurate diagnosis. These exclusions were: six due to acute bronchitis (H06) being coded as COPD (H3z); 16 due to an never smoked (1371), passive smoker (137I), chews tobacco (137W), as well as codes for being a current and ex-smoker.
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Accuracy
On inspection of the computerised records it was possible to exclude the diagnosis of COPD in 24.7% (47/190) patients because of an inaccurate diagnosis. These exclusions were: six due to acute bronchitis (H06) being coded as COPD (H3z); 16 due to an asthma coding and no evidence of concurrent COPD; 25 due to a single coding for COPD in the history, but no investigation or treatment data compatible with the diagnosis. After excluding the inaccurately diagnosed patients there remained 143 COPD patients. These have a mean age of 70 years (range 44-94 years). Figure 5 shows the completeness and accuracy of the audit search in diagrammatic form. Those with COPD were more likely to be smokers or ex-smokers, and those recorded as having never smoked were much less likely to have COPD (Chisquared test PϽ0.01, see Table 2 ).
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Assessing diagnostic data quality in practice 249 Of the 143 accurately coded patients, 31 (21.7%) had FEV1 measurements within the recommended 27-month period. A further 64 (44.8%) had a value more than 27 months old, and the remainder had no recorded values. Figure 4 represents this diagrammatically, and Figure 6 shows the time since last FEV1 measure.
Clinicians were divided about what was appropriate currency for these data. Some felt that an FEV1 and FVC should be recorded once for diagnostic purposes, or an indication given that the diagnosis was based on spirometry performed in secondary care. If a patient had few exacerbations, and was well, there was little enthusiasm for prioritising spirometry over other clinical tasks; but they would comply to fit with their contract. It was clear that the different general practitioners used the diagnosis of COPD differently.
Some were likely to make the diagnosis clinically, especially in a wheezy smoker without a history of asthma or atopy; others were much more reticent. All believed smoking should be recorded, and opinions were divided on spirometry. Prospectively, new COPD diagnoses would only be made based on spirometry.
Sensitivity and positive predictive value
The sensitivity (that is, the proportion of those who really have COPD who have a diagnostic code) is 79.0%. The positive predictive value (that is, the likelihood that someone with the diagnostic code actually has the disease) is 75.3%. The figures and the calculation are shown in Table 3 . Figure 4 represents this diagrammatically, and Figure 6 shows the time since last FEV1 measure.
The sensitivity (that is, the proportion of those who really have COPD who have a diagnostic code) is 79.0%. The positive predictive value (that is, the likelihood that someone with the diagnostic code actually has the disease) is 75.3%. The figures and the calculation are shown in Table 3 . 
Discussion

Principal findings
The diagnostic data available has a sensitivity and positive predictive value that suggests it is accurate roughly three-quarters of the time. Sins of commission were as big a problem as sins of omission (that is, coding patients with a disease incorrectly was as big a problem as failing to code patients whom other data suggest had the disease). The weaknesses of these data were their incompleteness, inaccuracy and lack of currency. The idiosyncratic nature of the coding hierarchy in this domain, and lack of clarity in the interface in the clinical computer system between acute and chronic bronchitis, contributed to the data quality being poor.
Implications for practice
Practitioners should be more aware of the coding hierarchy and take care not to label patients inappropriately with a code that means they will be included in the practice COPD population. Hospital outpatient letters and discharge summaries need to include the results of any relevant tests so that the results can be coded in GP electronic records. Contractual changes are going to result in much improved consistency in diagnostic data recording in COPD; however, this may distort coding by reducing primary care professionals' willingness to make a clinical diagnosis. 7 
Limitations of the method
The criteria used to search for COPD patients who did not have the appropriate diagnostic code might not have been exhaustive. The population size of the GP surgery used was such that it was not feasible to look through all of the records individually, and it is acknowledged that the apparent prevalence of COPD could have been higher if this had been done. COPD, FEV1 and smoking results were the only variables that have been analysed. The study was conducted in a single practice which is relatively advanced in its use of information technology; the findings therefore may not be generalisable to practices with lower levels of data recording unless there is time to carry out exhaustive searches of the written records. We considered extracting free-text entries from the computerised record, and then searching these records using a standard spreadsheet package for key words; for example, 'FEV1'. It is also possible to run exported free text through more sophisticated natural language processing (NLP) packages such as CliniViewer, or to use other more sophisticated methods to explore clinical data (for example, KNAVE-II and ISABEL). [27] [28] [29] We rejected this approach as our aim was to produce a tool that could be readily used by a non-expert; however, this decision should be reconsidered as this technology becomes more accessible to ordinary users.
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Comparison with literature
Little has been published about data quality in COPD. However, studies of the prevalence of COPD find airways obstruction in as many as 24.3% of smokers aged over 40, and with severe obstruction in over 5%. 30 It would appear likely that prevalence of COPD is underestimated. The sensitivity and positive predictive values obtained for COPD in this study are much lower than most of those obtained by Hassey et al in 2001; however, they did not include COPD in their basket of diagnoses, perhaps because of some of the associated coding difficulties. 12 Although the literature on what makes a data quality programme effective has been reviewed, little has been written about how to go about examining diagnostic data quality at the individual practice or locality level, other than the work done by the PRIMIS Team. 19, 31 Brown and Warmington have used data quality probes extensively in their own practice to improve data quality. 14 We could not identify ways that that approach could be used here because of the lack of a drug or widely-recorded test result that is readily associated with the diagnosis. Finding people who have never smoked with COPD is not unusual, and our proportion of those who had never smoked (11.5%) was less than that found by Meyer et al (16.7%). 32 
Call for further research
Other disease areas and clinical systems should be examined to see if the problems are limited to one clinical system and one specific respiratory disease. Further research should investigate the influence of financially incentivised quality targets on clinical coding.
Conclusions
COPD is a diagnosis which is not ideally situated within the coding hierarchy, and without well-recorded surrogate markers, yet it is one where there is scope for quality improvement. The inclusion of COPD in the UK's new quality-based contract for general practice will ensure its prominence in general practitioners' minds. This method provides a tool for the measurement of data quality in a single practice, taking into account the broad range of factors which might affect data quality.
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